Your browser doesn't support javascript.
loading
Durvalumab Plus Olaparib in Previously Untreated, Platinum-Ineligible Patients With Metastatic Urothelial Carcinoma: A Multicenter, Randomized, Phase II Trial (BAYOU).
Rosenberg, Jonathan E; Park, Se Hoon; Kozlov, Vadim; Dao, Tu V; Castellano, Daniel; Li, Jian-Ri; Mukherjee, Som D; Howells, Kathryn; Dry, Hannah; Lanasa, Mark C; Stewart, Ross; Bajorin, Dean F.
Afiliação
  • Rosenberg JE; Genitourinary Oncology Service, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Park SH; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Kozlov V; Novosibirsk Reg Clinical Onc Dispensary, Novosibirsk, Russia.
  • Dao TV; Vietnam National Cancer Hospital, Hanoi, Vietnam.
  • Castellano D; Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Li JR; Taichung Veterans General Hospital, Hung Kuang University, Taichung, Taiwan.
  • Mukherjee SD; Juravinski Cancer Centre, Hamilton Health Sciences and McMaster University, Hamilton, Ontario, Canada.
  • Howells K; AstraZeneca, Cambridge, United Kingdom.
  • Dry H; AstraZeneca, Gaithersburg, MD.
  • Lanasa MC; AstraZeneca, Gaithersburg, MD.
  • Stewart R; AstraZeneca, Cambridge, United Kingdom.
  • Bajorin DF; Genitourinary Oncology Service, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.
J Clin Oncol ; 41(1): 43-53, 2023 01 01.
Article em En | MEDLINE | ID: mdl-35737919
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article